Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
10 Cards in this Set
- Front
- Back
Systolic Dysfunction in CHF
|
Decreased ejection fraction
Causes: 1) Recent MI 2) Cardiomyopathy 3) Myocarditis |
|
Diastolic Dysfunction in CHF
|
Impaired ventricular filling in diastole (impaired relaxation of Left ventricle
Causes: 1) HTN --> myocardial hypertrophy 2) Valvular diseases (aortic stenosis, mitral stenosis, aortic regurg) 3) Restrictive cardiomyopathy |
|
Symptoms of Left-Sided Heart Failure
|
1) Dyspnea - 2/2 pulmonary congestion
2) Orthopnea 3) Paroxysmal Nocturnal Dyspnea (PND) 4) NOCTURNAL COUGH 5) CONFUSION & MEMORY IMPAIRMENT - 2/2 inadequate brain perfusion 6) Diaphoresis and cool extremities at rest |
|
Signs of Left-Sided Heart Failure
|
1) Displaced PMI - 2/2 cardiomegaly
2) Pathologic S3 3) Pathologic S4 4) Crackles/rales at lung bases 5) Dullness to percussion and decreased tactile fremitus of lower lung fields - 2/2 pleural effusion 6) Increased intensity of pulmonic component of S2 - 2/2 pulmonary HTN |
|
New York Heart Association (NYHA) Classification of CHF
|
NYHA Class I: Symptoms only with vigorous activity
NYHA Class II: Symptoms with prolonged or moderate exertion NYHA Class III: Symptoms with activities of daily living (getting dressed) NYHA Class IV: Symptoms at rest |
|
Symptoms/Signs of Right-Sided Heart Failure
|
1) Peripheral pitting edema
2) Nocturia - 2/2 increased venous return with leg elevation 3) Jugular venous distention 4) Hepatomegaly/hepatojugular reflex 5) Ascities 6) Right ventricular heave |
|
Diagnosis of CHF
|
1) CXR
2) Echocardiogram (systolic vs. diastolic dysfunction) 3) Radionuclide ventriculography w/ technetium-99m 4) Cardiac catheterization (CAD as cause?) 5) Stress testing |
|
Treatment of CHF
|
1) Sodium restriction: <4g/day
2) Diuretics 3) ACE Inhibitors (and ARBs) 4) Beta-blockers 5) Digitalis 6) Hydralazine and isosorbide dinitrates *ACEIs REDUCE MORTALITY, prolong survival, and alleviate symptoms *B-Blockers DECREASE MORTALITY in patients POST-MI heart failure |
|
Which classes of heart failure show reduced morbidity and mortality with Spironolactone?
|
Class III and Class IV
*Contraindicated in renal failure |
|
B-type Natriuretic Peptide (BNP)
|
Released from ventricles in response to increased volume and pressure overload
*Levels >100pg/ml = decompensated CHF |